Submit or Track your Manuscript LOG-IN

Effect of Mesalazine Combined with Bifid Triple Viable on Ulcerative Colitis

Effect of Mesalazine Combined with Bifid Triple Viable on Ulcerative Colitis

Qi Zhao1, Yuanyuan Hou1, Xiangdong Jin1 and Chen Zhang 2,*

1Department of Medical Technology and Engineering, Zhengzhou Railway Vocational and Technical College, Zhengzhou, 451460, China.
2Preventive Dentistry,The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450002, China
* Corresponding author:


Objective of this study was to observe the clinical effect of mesalazine combined with bifid triple viable (BTV) on ulcerative colitis. One hundred sixty patients with ulcerative colitis were divided into the experimental group accepting mesalazine combined with BTV and the control group accepting mesalazine alone. It was found that the overall treatment effective rate was 93.75%, in the experimental group as against 77.50% in the control group, p<0.05. Comparing the levels of inflammatory factors (IL-6,IL-8,TNF-α) before and after treatment in the two groups, the improvement degree of the experimental group after treatment was significantly better than that of the control group, p<0.05. The overall nursing satisfaction of the research group was 97.50%, which was significantly higher than the 75.00% of the control group, p<0.05. To conclude that combined therapy of mesalazine and BTV can significantly improve the therapeutic effect in patients with ulcerative colitis, and the scientific nursing mode is an important guarantee to improve the therapeutic results.


To share on other social networks, click on any share button. What are these?

Pakistan Journal of Zoology


Vol. 54, Iss. 4, Pages 1501-2001


Click here for more

Subscribe Today

Receive free updates on new articles, opportunities and benefits

Subscribe Unsubscribe